Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Analysis of IFN-gamma and IL-10 Levels as Markers of Inflammation and Response Therapy of Anti-Tuberculosis in MDR Lung TB Patients

Folia Medica Indonesiana · Vol. 55 No. 4 (2020) · hlm. 268–268

DOI
10.20473/fmi.v55i4.24394
ISSN
2355-8393, 2599-056X
Terbit
2020-01-13
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Multidrug-Resistant Tuberculosis (MDR TB) is caused by an organism that is resistant to at least isoniazid and rifampisin, the two most potent TB drug. Immune response to against Mycobacterum tuberculosis infection is related to the function of immunity. The function of interferon-γ (pro-inflammatory) is to activate macrophages, to stimulate antimicrobial molecules (to reactive oxygen species and nitric oxide), and to inhibits interleukin-10. Interleukin-10 function is to triggers humoral immunity, to inhibit IFN- γ. This study aimed to analyze level changes and the correlation with clinical data, also months of MDR TB patients who received standard OAT therapy. This was an observational study using cross sectional design. There were 29 patients who received standard MDR TB OAT therapy from 1-24 months, who met the inclusion criteria. Then, the patients were divided based on duration of the therapy, which are the initial/intensive and advanced phase. The initial phase divided into 2: first one is for 1-4 months therapy’s time (5 patients) and the second one is for more than 4-8 months (6 patients). Then, the advanced group divided into two groups again, which are third group with more than 8-16 months (13 patients) and fouth group with more than 16-24 months (5 patients). Then, measured serum concentration IFN-γ, IL-10 at the start of the study and 4 weeks later with the ELISA method. This research during the period July-December (6 months). IFN-γ post concentrations were decreased by 39.14 ± 139.12 pg/mL (p > 0.05). The concentration of IL-10 was decreased by 33.93 ± 109.20pg/mL (p>0.05). Based on the TB score bandim method during pre and posts results were 1 patient experienced severity change from severity class 1 to 2, 1 patient from severity class 2 to 1, 1 patient remained in severity 2 and 26 patient remained in severity 1. The results showed that serum IFN-γ and IL-10 levels in initial/intensive and advanced phase patients who received MDR TB regiment after four weeks did not changed,

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 99 tautan kepenulisan bersama · 39 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • RSUD Prof. Dr. Saiful Anwar Malang
  • University of Brawijaya
  • Rumah Sakit Umum Haji Surabaya
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mariyatul QibtiyahRumah Sakit Dokter Soetomo3
Didik HasmonoUniversitas Airlangga2
Nun ZairinaRumah Sakit Dokter Soetomo2
Binti MuzayyanahUniversitas Airlangga1
Nuraida WisudaniAfiliasi tidak diketahui1
Arief BakhtiarUniversitas Airlangga1
Bambang Pudjo SemediUniversitas Airlangga1
Rosy SetiawatiRumah Sakit Dokter Soetomo1
Resti Yudhawati MelianaRumah Sakit Dokter Soetomo1
Tutik KusmiatiRumah Sakit Dokter Soetomo1
Ariani PermatasariRumah Sakit Dokter Soetomo1
Irmi Syafa’ahRumah Sakit Dokter Soetomo1
Dwi Wahyu IndrawantoRumah Sakit Dokter Soetomo1
Eddy Zarkaty MRumah Sakit Umum Haji Surabaya1
Teri Wina HerwatiUniversitas Airlangga1
Budi SupraptiUniversitas Airlangga1
Mida PurwiningtyasUniversitas Airlangga1
Bayu Dharma SantiAfiliasi tidak diketahui1
Desantika WuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Bagus Putu Putra SuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Octaviana Maria SimbolonUniversitas Airlangga1
I Dg UgrasenaUniversitas Airlangga1
Febriansyah Nur UtomoRumah Sakit Dokter Soetomo1
Bambang PermonoRumah Sakit Dokter Soetomo1
Mia Ratwita AndarsiniUniversitas Airlangga1
Levana RismayantiUniversitas Airlangga1
Nur OktaviaUniversitas Airlangga1
Unedo Hence Markus SihombingAfiliasi tidak diketahui1
Hendriette Irene MamoUniversitas Airlangga1
Darto SaharsoRumah Sakit Dokter Soetomo1
Melawati OlevianingrumAfiliasi tidak diketahui1
Susanto NugrohoUniversity of Brawijaya1
Sri WinarsihRSUD Prof. Dr. Saiful Anwar Malang1
Reta Anggraeni WidyaUniversitas Airlangga1
Suharjono SuharjonoUniversity of Brawijaya1
Ekanita DesianiUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Analysis of IFN-gamma and IL-10 Levels as Markers of Inflammation and Response Therapy of Anti-Tuberculosis in MDR Lung TB Patients</dc:title><dc:creator>Herni Setyawati</dc:creator><dc:creator>Soedarsono Soedarsono</dc:creator><dc:creator>Yulistiani Yulistiani</dc:creator><dc:creator>Umi Fatmawati</dc:creator><dc:subject>multidrug-resistant tuberculosis</dc:subject><dc:subject>interferon-gamma</dc:subject><dc:subject>IL-10</dc:subject><dc:subject>serum cytokines</dc:subject><dc:subject>inflammatory markers</dc:subject><dc:subject>tuberculosis treatment</dc:subject><dc:subject>treatment response</dc:subject><dc:subject>Mycobacterium tuberculosis</dc:subject><dc:subject>macrophage activation</dc:subject><dc:description xml:lang="en">Multidrug-Resistant Tuberculosis (MDR TB) is caused by an organism that is resistant to at least isoniazid and rifampisin, the two most potent TB drug. Immune response to against Mycobacterum tuberculosis infection is related to the function of immunity. The function of interferon-γ (pro-inflammatory) is to activate macrophages, to stimulate antimicrobial molecules (to reactive oxygen species and nitric oxide), and to inhibits interleukin-10. Interleukin-10 function is to triggers humoral immunity, to inhibit IFN- γ. This study aimed to analyze level changes and the correlation with clinical data, also months of MDR TB patients who received standard OAT therapy. This was an observational study using cross sectional design. There were 29 patients who received standard MDR TB OAT therapy from 1-24 months, who met the inclusion criteria. Then, the patients were divided based on duration of the therapy, which are the initial/intensive and advanced phase. The initial phase divided into 2: first one is for 1-4 months therapy’s time (5 patients) and the second one is for more than 4-8 months (6 patients). Then, the advanced group divided into two groups again, which are third group with more than 8-16 months (13 patients) and fouth group with more than 16-24 months (5 patients). Then, measured serum concentration IFN-γ, IL-10 at the start of the study and 4 weeks later with the ELISA method. This research during the period July-December (6 months). IFN-γ post concentrations were decreased by 39.14 ± 139.12 pg/mL (p &gt; 0.05). The concentration of IL-10 was decreased by 33.93 ± 109.20pg/mL (p&gt;0.05). Based on the TB score bandim method during pre and posts results were 1 patient experienced severity change from severity class 1 to 2, 1 patient from severity class 2 to 1, 1 patient remained in severity 2 and 26 patient remained in severity 1. The results showed that serum IFN-γ and IL-10 levels in initial/intensive and advanced phase patients who received MDR TB regiment after four weeks did not changed,</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2020-01-13</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v55i4.24394</dc:identifier><dc:identifier>10.20473/fmi.v55i4.24394</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 55 No 4 (2020); 268-268</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/24394/13260</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>